Ironwood Pharmaceuticals Inc (IRWD)
6.595
-0.04
(-0.68%)
USD |
NASDAQ |
May 17, 10:35
Ironwood Pharmaceuticals Free Cash Flow: 147.91M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 147.91M |
| December 31, 2023 | 183.15M |
| September 30, 2023 | 226.74M |
| June 30, 2023 | 263.36M |
| March 31, 2023 | 289.67M |
| December 31, 2022 | 273.63M |
| September 30, 2022 | 258.86M |
| June 30, 2022 | 264.76M |
| March 31, 2022 | 252.05M |
| December 31, 2021 | 261.63M |
| September 30, 2021 | 248.68M |
| June 30, 2021 | 227.38M |
| March 31, 2021 | 198.52M |
| December 31, 2020 | 166.99M |
| September 30, 2020 | 140.42M |
| June 30, 2020 | 118.48M |
| March 31, 2020 | 88.09M |
| December 31, 2019 | 3.536M |
| September 30, 2019 | -12.36M |
| June 30, 2019 | -69.28M |
| March 31, 2019 | -81.22M |
| December 31, 2018 | -71.23M |
| September 30, 2018 | -89.06M |
| June 30, 2018 | -96.54M |
| March 31, 2018 | -107.07M |
| Date | Value |
|---|---|
| December 31, 2017 | -103.56M |
| September 30, 2017 | -115.13M |
| June 30, 2017 | -84.46M |
| March 31, 2017 | -158.18M |
| December 31, 2016 | -130.14M |
| September 30, 2016 | -129.91M |
| June 30, 2016 | -154.52M |
| March 31, 2016 | -74.05M |
| December 31, 2015 | -110.98M |
| September 30, 2015 | -114.65M |
| June 30, 2015 | -127.16M |
| March 31, 2015 | -137.69M |
| December 31, 2014 | -159.11M |
| September 30, 2014 | -181.08M |
| June 30, 2014 | -200.86M |
| March 31, 2014 | -246.02M |
| December 31, 2013 | -282.95M |
| September 30, 2013 | -262.99M |
| June 30, 2013 | -168.62M |
| March 31, 2013 | -132.03M |
| December 31, 2012 | -83.61M |
| September 30, 2012 | -69.12M |
| June 30, 2012 | -130.54M |
| March 31, 2012 | -105.24M |
| December 31, 2011 | -84.92M |
Free Cash Flow Range, Past 5 Years
-69.28M
Minimum
Jun 2019
289.67M
Maximum
Mar 2023
176.61M
Average
212.63M
Median
Free Cash Flow Benchmarks
| AbbVie Inc | 21.89B |
| Societal CDMO Inc (DELISTED) | -9.242M |
| Amicus Therapeutics Inc | -88.03M |
| Insmed Inc | -588.55M |
| InfuSystems Holdings Inc | 3.244M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 44.98M |
| Cash from Investing (Quarterly) | -0.068M |
| Cash from Financing (Quarterly) | -15.56M |
| Free Cash Flow Per Share (Quarterly) | 0.2848 |
| Free Cash Flow to Equity (Quarterly) | 69.51M |
| Free Cash Flow to Firm (Quarterly) | 39.83M |
| Free Cash Flow Yield | 13.68% |